Intelomed, Inc. Receives CE Marking, Plans to Expand Business Beyond the United States

WEXFORD, Pa., Nov. 5, 2014 /PRNewswire/ --  Intelomed, Inc. received CE Marking this week, thus allowing it to expand its marketing efforts beyond the United States. "Obviously, achieving CE Mark is critical to our global strategy, said Frank Amoruso, President and CEO.  "CVInsight, our non-invasive tool for assessing and monitoring cardiovascular stress, can be of great value in many areas of health care, both in the United States and across the globe."  

When asked about the impact the mark will have on future opportunities, Mr. Amoruso commented that "several of our most valued relationships are expressing interest in alliances beyond the domestic market; by pursuing and achieving our CE Mark, we can meet the need for broader relationships."  

About Intelomed

Intelomed is a privately held medical technology company, established in 2005 and headquartered in Pittsburgh, Pennsylvania. They have developed a non-invasive hemodynamic monitor for monitoring cardiovascular stability in real-time. Intelomed's ability to provide intelligent operational medicine via their technology will directly and positively impact the initial areas of dialysis, heart failure and hospitalization.  

Safe Harbor Statement

Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on third party manufacturers to produce our goods on time and to our specifications, and implementation of our sales strategy.

Logo - http://photos.prnewswire.com/prnh/20140227/MM74067LOGO

SOURCE Intelomed, Inc.

Related Links

http://www.intelomed.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED